Acadian Asset Management
LKFT

Acadian Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Acadian Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Sell
23,701
-22,241
-48% -$631K ﹤0.01% 1358
2026
Q1 		$1.37M Buy
45,942
+38,401
+509% +$1.27M ﹤0.01% 1072
2025
Q4 		$246K Buy
+7,541
New +$243K ﹤0.01% 1476
2024
Q3 		– Sell
-844
Closed -$20K – 2182
2024
Q2 		$20K Sell
844
-14,342
-94% -$407K ﹤0.01% 1679
2024
Q1 		$488K Buy
15,186
+2,366
+18% +$88K ﹤0.01% 1011
2023
Q4 		$520K Sell
12,820
-6,329
-33% -$233K ﹤0.01% 1020
2023
Q3 		$661K Buy
19,149
+12,154
+174% +$473K ﹤0.01% 941
2023
Q2 		$284K Buy
6,995
+3,722
+114% +$152K ﹤0.01% 1193
2023
Q1 		$126K Buy
+3,273
New +$135K ﹤0.01% 1348
2022
Q2 		– Sell
-412
Closed -$25K – 1742
2022
Q1 		$25K Buy
+412
New +$25.2K ﹤0.01% 1548
2021
Q2 		– Sell
-14,087
Closed -$1.09M – 2076
2021
Q1 		$1.09M Buy
+14,087
New +$1.3M ﹤0.01% 930
2020
Q4 		– Sell
-39,725
Closed -$5.64M – 2258
2020
Q3 		$5.64M Sell
39,725
-29,657
-43% -$4.94M 0.02% 414
2020
Q2 		$13.7M Sell
69,382
-4,744
-6% -$983K 0.06% 275
2020
Q1 		$14.5M Buy
74,126
+28,146
+61% +$6.06M 0.08% 204
2019
Q4 		$9.51M Buy
+45,980
New +$8.5M 0.04% 319
2017
Q3 		– Sell
-2,173
Closed -$166K – 1446
2017
Q2 		$166K Buy
+2,173
New +$183K ﹤0.01% 969
2017
Q1 		– Sell
-11,810
Closed -$758K – 1638
2016
Q4 		$758K Buy
+11,810
New +$727K ﹤0.01% 772

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Acadian Asset Management's LKFT Position: Q2 2026 in Review

Acadian Asset Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 48% in Q2 2026, selling an estimated $631K and leaving 23,701 shares worth $709K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Acadian Asset Management first reported a position in LKFT in Q4 2016 and has held it in 17 quarters since. The position peaked at $14.5M in Q1 2020. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Acadian Asset Management held 23,701 shares of Lakefront Biotherapeutics American Depositary Shares worth $709K as of Q2 2026.
  • Acadian Asset Management sold 22,241 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $631K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1358 holding.
  • Acadian Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and has held it in 17 quarters since.
  • Acadian Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $14.5M in Q1 2020.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.